Completed PHASE2 INTERVENTIONAL 2-arm NCT01928849

Valproic Acid for the Prevention of Post-Amputation Pain

Regional Anesthesia and Valproate Sodium for the Prevention of Chronic Post-Amputation Pain

Sponsor: Duke University

Conditions Pain, Neuropathic Pain, Phantom

Interventions Cherry Syrup Valproic Acid

Updated 11 times since 2017 Last updated: Nov 28, 2018 Started: Dec 31, 2013 Primary completion: Sep 26, 2017 Completion: Sep 26, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01928849, this PHASE2 trial focuses on Pain, Neuropathic and Pain, Phantom and remains completed. Sponsored by Duke University, it has been updated 11 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 6 earlier versions

Jan 2019 — Jan 2021 [monthly]

Completed PHASE2
Nov 2018 — Jan 2019 [monthly]

Completed PHASE2
Jun 2018 — Nov 2018 [monthly]

Completed PHASE2
Nov 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Feb 2017 — Nov 2017 [monthly]

Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke University
United States Department of Defense

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States
• Durham, United States